DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842,300 | -0.4% | 3,395 | -3.7% | 0.07% | +4.3% |
| Q2 2023 | $845,760 | -16.4% | 3,524 | -12.2% | 0.07% | -9.1% |
| Q1 2023 | $1,011,688 | +89988.0% | 4,014 | -5.2% | 0.08% | -7.2% |
| Q4 2022 | $1,123 | -99.9% | 4,233 | -1.3% | 0.08% | -6.7% |
| Q3 2022 | $1,108,000 | +33.2% | 4,290 | +30.6% | 0.09% | +41.3% |
| Q2 2022 | $832,000 | +276.5% | 3,284 | +335.0% | 0.06% | +200.0% |
| Q1 2022 | $221,000 | -7.1% | 755 | +4.4% | 0.02% | -8.7% |
| Q4 2021 | $238,000 | +8.2% | 723 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $220,000 | -6.8% | 723 | -17.9% | 0.02% | -8.0% |
| Q2 2021 | $236,000 | -12.3% | 881 | -29.6% | 0.02% | -37.5% |
| Q3 2020 | $269,000 | +13.5% | 1,252 | -6.6% | 0.04% | +21.2% |
| Q2 2020 | $237,000 | -33.6% | 1,340 | -48.1% | 0.03% | -62.9% |
| Q1 2020 | $357,000 | -17.7% | 2,582 | -8.8% | 0.09% | -8.2% |
| Q4 2019 | $434,000 | +6.1% | 2,832 | 0.0% | 0.10% | +2.1% |
| Q3 2019 | $409,000 | -36.1% | 2,832 | -36.8% | 0.10% | -33.1% |
| Q2 2019 | $640,000 | +2.6% | 4,482 | -5.2% | 0.14% | +2.2% |
| Q1 2019 | $624,000 | +28.9% | 4,727 | +0.7% | 0.14% | +15.8% |
| Q4 2018 | $484,000 | +15.0% | 4,693 | +21.0% | 0.12% | +34.8% |
| Q3 2018 | $421,000 | +9.4% | 3,878 | -0.7% | 0.09% | +4.7% |
| Q2 2018 | $385,000 | +0.3% | 3,904 | -0.5% | 0.08% | -2.3% |
| Q1 2018 | $384,000 | +18.2% | 3,923 | +12.2% | 0.09% | +26.1% |
| Q4 2017 | $325,000 | -11.7% | 3,496 | -18.6% | 0.07% | -12.7% |
| Q3 2017 | $368,000 | +27.3% | 4,296 | +25.4% | 0.08% | +31.7% |
| Q2 2017 | $289,000 | +21.4% | 3,427 | +23.1% | 0.06% | +22.4% |
| Q1 2017 | $238,000 | +4.4% | 2,785 | -5.1% | 0.05% | +8.9% |
| Q4 2016 | $228,000 | -0.9% | 2,935 | 0.0% | 0.04% | -4.3% |
| Q3 2016 | $230,000 | -28.6% | 2,935 | -7.9% | 0.05% | -29.9% |
| Q2 2016 | $322,000 | -0.3% | 3,188 | -6.2% | 0.07% | -1.5% |
| Q1 2016 | $323,000 | -3.3% | 3,400 | -5.6% | 0.07% | -1.4% |
| Q4 2015 | $334,000 | +15.6% | 3,600 | +6.3% | 0.07% | +11.3% |
| Q3 2015 | $289,000 | -0.3% | 3,388 | 0.0% | 0.06% | +40.9% |
| Q2 2015 | $290,000 | +0.7% | 3,388 | 0.0% | 0.04% | -2.2% |
| Q1 2015 | $288,000 | -19.1% | 3,388 | -18.4% | 0.04% | -23.7% |
| Q4 2014 | $356,000 | +26.7% | 4,151 | +12.2% | 0.06% | -1.7% |
| Q3 2014 | $281,000 | -19.0% | 3,701 | -15.9% | 0.06% | -15.5% |
| Q2 2014 | $347,000 | +2.1% | 4,402 | -2.9% | 0.07% | -5.3% |
| Q1 2014 | $340,000 | -7.9% | 4,535 | -5.0% | 0.08% | -16.7% |
| Q4 2013 | $369,000 | +25.1% | 4,775 | +12.2% | 0.09% | +13.9% |
| Q3 2013 | $295,000 | +2.1% | 4,255 | -6.6% | 0.08% | -12.2% |
| Q2 2013 | $289,000 | – | 4,558 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |